![](/img/cover-not-exists.png)
519PFOLFOXIRI + BEVACIZUMAB (BEV) IN PATIENTS (PTS) WITH PREVIOUSLY UNTREATED METASTATIC COLORECTAL CANCER (MCRC): FINAL SURVIVAL AND PHARMACOGENOMIC PROFILING RESULTS FROM THE OPAL STUDY
Stein, A., Atanackovic, D., Stoehlmacher, J., Hildebrandt, B., Stübs, P., Steffens, C., Brugger, W., Hapke, G., Illerhaus, G., Bluemner, E., Bokemeyer, C.Volume:
25
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu333.22
Date:
September, 2014
File:
PDF, 67 KB
2014